CLINICAL TRIALS PROFILE FOR TOPAMAX SPRINKLE
✉ Email this page to a colleague
All Clinical Trials for TOPAMAX SPRINKLE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00648934 ↗ | Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2005-11-01 | The objective of this study was to investigate the bioequivalence of Mylan's topiramate sprinkle 25 mg capsules to Ortho-McNeil's Topamax® Sprinkle 25 mg capsules following a single, oral 25 mg (1 x 25 mg) dose administered under fed conditions. |
NCT00649467 ↗ | Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2005-11-01 | The objective of this study was to investigate the bioequivalence of Mylan's topiramate sprinkle 25 mg capsule to Ortho-McNeil's Topamax® Sprinkle 25 mg capsule following a single, oral 25 mg (1 x 25 mg) dose sprinkled on one teaspoon of applesauce under fasting conditions. |
NCT00649740 ↗ | Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2005-11-01 | The objective of this study was to investigate the bioequivalence of Mylan's topiramate sprinkle 25 mg capsule to Ortho-McNeil's Topamax® Sprinkle 25 mg capsule following a single, oral 25 mg (1 x 25 mg) dose administered under fasting conditions. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TOPAMAX SPRINKLE
Condition Name
Clinical Trial Locations for TOPAMAX SPRINKLE
Trials by Country
Clinical Trial Progress for TOPAMAX SPRINKLE
Clinical Trial Phase
Clinical Trial Sponsors for TOPAMAX SPRINKLE
Sponsor Name